Ratnasari_2022_PLoS.One_17_e0263298

Reference

Title : Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients - Ratnasari_2022_PLoS.One_17_e0263298
Author(s) : Ratnasari N , Lestari P , Renovaldi D , Raditya Ningsih J , Qoriansas N , Wardana T , Hakim S , Signa Aini Gumilas N , Indrarti F , Triwikatmani C , Bayupurnama P , Setyo Heriyanto D , Astuti I , Mubarika Harjana S
Ref : PLoS ONE , 17 :e0263298 , 2022
Abstract : Ratnasari_2022_PLoS.One_17_e0263298
ESTHER : Ratnasari_2022_PLoS.One_17_e0263298
PubMedSearch : Ratnasari_2022_PLoS.One_17_e0263298
PubMedID: 35157721

Related information

Citations formats

Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, Hakim S, Signa Aini Gumilas N, Indrarti F, Triwikatmani C, Bayupurnama P, Setyo Heriyanto D, Astuti I, Mubarika Harjana S (2022)
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
PLoS ONE 17 :e0263298

Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, Hakim S, Signa Aini Gumilas N, Indrarti F, Triwikatmani C, Bayupurnama P, Setyo Heriyanto D, Astuti I, Mubarika Harjana S (2022)
PLoS ONE 17 :e0263298